跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SITAGLIPTINA GRINDEKS 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SITAGLIPTINA GRINDEKS 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
SITAGLIPTINA GRINDEKS 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Grindeks As
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 28, 2022
Approval ID
4f3dff645c3121e5
Company
Grindeks As
Type
Standard
Approval Details
Approval Id
4f3dff645c3121e5
Drug Cima Aemps Name
SITAGLIPTINA GRINDEKS 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
86984
Holder Company Name
Grindeks As
Marketing Company Name
Grindeks Kalceks Espana S.L.
Holder Company Detail Path
/organization/grindeks-as
Authorization Date
2022-04-28
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
25 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Grindeks As
Company Detail Path
/organization/grindeks-as
Company Information
Pharmaceutical Company Name
Grindeks AS
Country Name
Latvia
Website
http://grindeks.eu
Active Ingredients
SITAGLIPTINA HIDROCLORURO MONOHIDRATO
28,35 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 28, 2022
Approval ID
4f3dff645c3121e5
Type
Standard
Back to CIMA-AEMPS Approvals